OncoMed Signs Second Cancer Stem Cell Partner; This Time It's Bayer
Deal with Bayer to discover and develop Wnt pathway therapies follows 2007 deal with GSK focused on Notch pathway.
Deal with Bayer to discover and develop Wnt pathway therapies follows 2007 deal with GSK focused on Notch pathway.